bluebird bio, Inc. Quarterly Costs and Expenses in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
bluebird bio, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2012 to Q2 2024.
  • bluebird bio, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $75.5M, a 5.06% increase year-over-year.
  • bluebird bio, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $329M, a 19.5% increase year-over-year.
  • bluebird bio, Inc. annual Costs and Expenses for 2023 was $333M, a 3.63% decline from 2022.
  • bluebird bio, Inc. annual Costs and Expenses for 2022 was $346M, a 41.9% decline from 2021.
  • bluebird bio, Inc. annual Costs and Expenses for 2021 was $595M, a 6.31% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $329M $75.5M +$3.64M +5.06% Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-27
Q1 2024 $326M $71.4M -$7.65M -9.68% Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-13
Q4 2023 $333M $96M +$56.3M +142% Oct 1, 2023 Dec 31, 2023 10-K 2024-09-13
Q3 2023 $277M $86.2M +$1.31M +1.55% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $276M $71.9M -$35.3M -32.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-27
Q1 2023 $311M $79.1M -$34.9M -30.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-13
Q4 2022 $346M $39.7M -$97.6M -71.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-09-13
Q3 2022 $443M $84.9M -$70.6M -45.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $514M $107M -$47.7M -30.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $562M $114M -$33M -22.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $595M $137M -$2.11M -1.52% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-04
Q3 2021 $597M $155M +$23.7M +18% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $573M $155M +$11.2M +7.79% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $562M $147M +$2.51M +1.74% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $559M $139M -$101M -42.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-04
Q3 2020 $660M $132M -$87.6M -39.9% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-04
Q2 2020 $748M $144M -$72.3M -33.5% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-04
Q1 2020 $820M $144M -$39.2M -21.3% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-04
Q4 2019 $860M $241M +$64.3M +36.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 $795M $219M +$58M +35.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 $737M $216M +$59.5M +38% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 $678M $184M +$51.1M +38.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q4 2018 $627M $176M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 $161M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-18
Q2 2018 $156M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-18
Q1 2018 $133M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-18
Q2 2015 $138M $57M +$37.3M +190% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $100M $31.3M +$14.3M +83.9% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $86M $26M +$11.6M +79.9% Oct 1, 2014 Dec 31, 2014 10-K 2015-02-25
Q3 2014 $74.5M $23.4M +$10.8M +86.4% Jul 1, 2014 Sep 30, 2014 10-K 2015-02-25
Q2 2014 $63.7M $19.7M +$9.14M +86.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $54.5M $17M +$9.4M +123% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $45.1M $14.5M +$5.41M +59.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-25
Q3 2013 $39.7M $12.5M +$7.43M +145% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-25
Q2 2013 $32.3M $10.5M +$5.84M +125% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-25
Q1 2013 $26.4M $7.61M +$2.39M +45.7% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-25
Q4 2012 $24.1M $9.04M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-05
Q3 2012 $5.11M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-05
Q2 2012 $4.69M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-05
Q1 2012 $5.22M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.